The fast-spreading virus can take multiple routes into developing human nerve cells.

In October 2013, we created a new, full-time position to lead our CR efforts. Juergen Brokatzky-Geiger, formerly Global Head of Human Resources and a member of the Executive Committee, took on this role effective in February 2014.

The Novartis Faculty of Scholars initiative connects academic researchers with deep knowledge and big ideas to scientists in its drug discovery labs.

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

Ask Alan Frohman how he found out that he had glaucoma, and he'll quickly tell you that there were no warning signs.

The disease hobbles families and economies.

Investing in innovative treatments is vital to alleviate the suffering caused by multiple sclerosis (MS).

From an eccentric idea to a revolution in medicine – the history of immunotherapy and a peek into its future.

All treatments that exist today started with patients volunteering to participate in a study and healthcare professionals offering their expertise.

Novartis is developing an experimental drug for weight loss.